Sean McCarthy's Email & Phone

Sean McCarthy has more than 15 years of experience in the biotechnology industry, including business development, venture capital, program management, and research management. McCarthy joined CytomX in January 2011 from Pappas Ventures, where he was most recently a transactional partner and helped drive investments in therapeutic, medical device and molecular diagnostic companies. In this role he also led various company formation initiatives and provided strategic guidance to portfolio companies. Dr. McCarthy previously held positions at Millennium Pharmaceuticals and SGX Pharmaceuticals. Under Dr. McCarthy's leadership at SGX, the company entered into a wide range of strategic partnerships with major pharmaceutical companies including Eli Lilly, Roche, and Novartis, with whom a $515M oncology alliance was forged in March 2006. Prior to SGX, Dr. McCarthy served as associate director of program management at Millennium Pharmaceuticals, where he managed biotherapeutic assets for the firm. Dr. McCarthy was responsible for research into gene discovery and for management of several drug discovery programs; his discovery team invented novel genomic techniques for the identification of therapeutic proteins and played a central role in a major alliance with Eli Lilly & Co. Dr. McCarthy is the author of 17 peer reviewed scientific publications and a named inventor on six issued patents and 23 filed patent applications. He holds a D.Phil. from St. John's College, University of Oxford and a B.Sc. in Biochemistry and Pharmacology from King's College at University of London with first class honors. Dr. McCarthy completed his postdoctoral work at the DNAX Research Institute in Palo Alto and also holds an M.B.A. from UC San Diego Rady School of Management.